Upper endoscopy 2.
His labs showed a potassium of 2.5, he was started on potassium IV and sent to the ED for further evaluation.
He reports undergoing EGD which showed question of metastatic gastric lesions that were bleeding.
His HCT remained stable at 37.
He was then admitted to the MICU for an emergent upper endoscopy, which demonstrated erosive esophagitis, gastritis, and compression by tumor, with ulceration around the stent in his biliary duct without evidence of bleeding.
Status post cyst removal on his throat 5.
Diagnosed via ERCP with cholangiocarcinoma -Klatskin-type tumor - [**5-5**], external and internal left and right transhepatic catheter drains - [**6-/2142**] - exploratory laparotomy - extensive tumor involvement of the right anterior branch of the hepatic duct as well as positive lymph nodes in the posterior duodenum.
- [**12-7**] gemcitabine and cisplatin - [**2-4**] disease progression on staging CT - [**3-7**] started on capecitabine monotherapy - [**3-7**] biochemical evidence of disease progression, changed to Taxotere 75 mg/m3 for three weeks.
He received a total of four cycles of Taxotere - [**Date range (1) 61949**] received 1st cycle of FLOX chemotherapy   Social History: Lives with friends Former heavy drinker Quite smoking in late 90s (previously 1ppd)   Family History: Non contributory.
Upper endoscopy [**2144-8-21**]: Impression: Esophagitis Abnormal mucosa in the stomach Metal stent was seen in the biliary duct, with no evidence of bleeding from the duct, however there was ulceration on the mucosal fold across from the stent but no visable vessel or active bleeding.
[**2144-8-21**] 08:55PM   POTASSIUM-3.4 [**2144-8-21**] 08:55PM   HCT-31.8* [**2144-8-21**] 01:55PM   GLUCOSE-120* UREA N-19 CREAT-1.1 SODIUM-139 POTASSIUM-2.8* CHLORIDE-96 TOTAL CO2-37* ANION GAP-9 [**2144-8-21**] 01:55PM   ALT(SGPT)-14 CK(CPK)-152 ALK PHOS-57 AMYLASE-35 TOT BILI-0.7 [**2144-8-21**] 01:55PM   LIPASE-51 [**2144-8-21**] 01:55PM   cTropnT-<0.01 [**2144-8-21**] 01:55PM   CK-MB-3 [**2144-8-21**] 01:35PM   GLUCOSE-115* UREA N-19 CREAT-1.1 SODIUM-138 POTASSIUM-2.9* CHLORIDE-95* TOTAL CO2-31 ANION GAP-15 [**2144-8-21**] 01:35PM   GLUCOSE-115* UREA N-19 CREAT-1.1 SODIUM-138 POTASSIUM-2.9* CHLORIDE-95* TOTAL CO2-31 ANION GAP-15 [**2144-8-21**] 01:35PM   ALT(SGPT)-16 AST(SGOT)-26 ALK PHOS-61 AMYLASE-37 TOT BILI-0.7 [**2144-8-21**] 01:35PM   LIPASE-54 [**2144-8-21**] 01:35PM   WBC-7.5 RBC-4.72 HGB-12.6* HCT-37.6* MCV-80* MCH-26.7* MCHC-33.5 RDW-19.9* [**2144-8-21**] 01:35PM   NEUTS-78.0* LYMPHS-13.6* MONOS-7.3 EOS-1.1 BASOS-0.1 [**2144-8-21**] 01:35PM   PLT COUNT-251 [**2144-8-21**] 01:35PM   PT-14.9* PTT-21.2* INR(PT)-1.3*  [**2144-8-21**] 10:39AM   WBC-7.8# RBC-4.78 HGB-13.1* HCT-37.6* MCV-79* MCH-27.4 MCHC-34.9 RDW-19.5* [**2144-8-21**] 10:39AM   NEUTS-80.2* LYMPHS-12.5* MONOS-6.7 EOS-0.3 BASOS-0.2 [**2144-8-21**] 10:39AM   PLT COUNT-254 [**2144-8-21**] 10:39AM   GRAN CT-6270  Brief Hospital Course: # Hematemesis: The patient's hematemesis was thought to be secondary to the gastritis, esophagitis, and ulceration seen on upper endoscopy.
It was also possible that there was a componenet of [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 329**] [**Last Name (NamePattern1) **] tear secondary to delayed nausea and vomiting from chemotherapy.
- Initally patient had melena and guaiac positive stools, thought to be secondary to his upper gastrointestinal source.
These cleared as treatment for his esophagitis and gastritis was initiated, and no further work-up was completed, as his bowel movements returned to baseline and were guaiac negative.
His hematocrit remained relatively stable during his admission, however drifted down slightly.
He was noted to have episodes where his heart rate was in the 30's to 40's at the time when he broke into sinus rhythm from atrial fibrillation.
At time of discharge, he remained in sinus rhythm with a rate in the 50's to 60's.
Blood and stool cultures were negative, and urine analysis did not suggest infection.
Medications on Admission: MS Contin 30mg Q12 MSIR 15mg Q4-5PRN   Discharge Medications: 1.
You were monitored closely and underwent an upper endoscopy that demonstrated inflammation, which was likely causing the bleeding.
Please call your primary care physician, [**Name10 (NameIs) **] oncologist, or go to the emergency room if you experience any vomiting, bleeding, fevers, chills, abdominal pain, chest pain, shortness of breath, or other concerning symptoms.
You also have the following upcoming appointments: Provider: [**First Name4 (NamePattern1) 2747**] [**Last Name (NamePattern1) 5780**], RN Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2144-8-28**] 10:30 Provider: [**Last Name (NamePattern4) **].
